BIOMAT Database Logo BIOMAT Database Logo

[Intensive chemotherapy of pulmonary tuberculosis]. 1980

M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010131 Aminosalicylic Acid An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid. 4-Aminosalicylic Acid,p-Aminosalicylic Acid,para-Aminosalicylic Acid,Alumino-4-Aminosalicylic Acid,Pamisyl,Rezipas,p-Aminosalicylic Acid Monolithium Salt,p-Aminosalicylic Acid Monopotassium Salt,p-Aminosalicylic Acid Monosodium Salt,p-Aminosalicylic Acid, Aluminum (2:1) Salt,p-Aminosalicylic Acid, Calcium (2:1) Salt,p-Aminosalicylic Acid, Monosodium Salt, Dihydrate,4 Aminosalicylic Acid,Acid, Aminosalicylic,Alumino 4 Aminosalicylic Acid,p Aminosalicylic Acid,p Aminosalicylic Acid Monolithium Salt,p Aminosalicylic Acid Monopotassium Salt,p Aminosalicylic Acid Monosodium Salt,para Aminosalicylic Acid
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
Intensive short-course chemotherapy in pulmonary tuberculosis.
January 1986, Indian journal of pediatrics,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Possibility and limitation of intensive chemotherapy of pulmonary tuberculosis].
May 1969, Kekkaku : [Tuberculosis],
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].
January 2004, Problemy tuberkuleza i boleznei legkikh,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
October 1997, Kekkaku : [Tuberculosis],
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Intensive chemotherapy regimens in pulmonary tuberculosis with concomitant diabetes mellitus].
September 1990, Vrachebnoe delo,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Effect of intensive chemotherapy on bacterial excretion in fibrocavernous pulmonary tuberculosis].
May 1979, Problemy tuberkuleza,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
Initial intensive chemotherapy in tuberculosis.
July 1973, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Chemotherapy of pulmonary tuberculosis].
September 1984, Meditsinskaia sestra,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Chemotherapy of pulmonary tuberculosis].
August 1984, Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
M V Shesterina, and V S Gavrilenko, and E F Tarasova, and G V Sokolova, and Iu G Tregubov
[Chemotherapy of pulmonary tuberculosis].
August 1969, Revista clinica espanola,
Copied contents to your clipboard!